Suchergebnisse - "1756-8919" OR "1756-8927"

PubPharm (10)

1

Structure-guided discovery of adenosine triphosphate-competitive casein kinase 2 inhibitors

enthalten in: Future medicinal chemistry | 2023

von Patel, S. | Vyas, V. | Sharma, M. | +1

2

Recent advances in the development of HIPK2 inhibitors as anti-renal fibrosis agents

enthalten in: Future medicinal chemistry | 2023

von Hao, C. | Cao, M. | Ouyang, H. | +3

3

Recent advances in ATM inhibitors as potential therapeutic agents

enthalten in: Future medicinal chemistry | 2022

von Dong, C. | Wang, Y. | Tu, Z. | +5

4

PLK1 inhibition in cancer therapy : potentials and challenges

enthalten in: Future medicinal chemistry | 2019

von Elsayed, I. | Wang, X.

5

Dual abrogation of MNK and mTOR : a novel therapeutic approach for the treatment of aggressive cancers

enthalten in: Future medicinal chemistry | 2017

von Lineham, E. | Spencer, J. | Morley, S.

6

DYRK1A inhibition as potential treatment for Alzheimer's disease

enthalten in: Future medicinal chemistry | 2016

von Stotani, S. | Giordanetto, F. | Medda, F.

7

Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands

enthalten in: Future medicinal chemistry | 2014

von Jennings, L. | Measures, A. | Wilson, B. | +1

8

Current understanding of LRRK2 in Parkinson's disease : biochemical and structural features and inhibitor design

enthalten in: Future medicinal chemistry | 2012

von Ray, S. | Liu, M.

9

Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance

enthalten in: Future medicinal chemistry | 2010

von Yamada, E. | Lee, T. | Pessin, J. | +1

10

Low-molecular-weight MK2 inhibitors : a tough nut to crack!

enthalten in: Future medicinal chemistry | 2009

von Schlapbach, A. | Huppertz, C.

1
[1]